UNH
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
- —
- Total sold
- —
- Last activity
- —
- Last synced
-
2026-08-04 10:23:03
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-06
UNH presents a moderate earnings catalyst (score 60, confidence 0.65) driven by Q2 2026 beats and improved guidance, but this positive signal is significantly undermined by weak financial health scores (liquidity: 45…
The first sentence of the analysis written for UNH on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 18.5% | 22.3% | 24.5% | 24.6% | 24.2% | |
| Ebit Margin | 4.2% | 6.0% | 8.7% | 8.8% | 8.3% | |
| Ebitda Margin | 5.2% | 7.0% | 9.8% | 9.8% | 9.4% | |
| Operating Profit Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | |
| Pretax Profit Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | |
| Continuous Operations Profit Margin | 2.9% | 3.8% | 6.2% | 6.4% | 6.2% | |
| Net Profit Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | |
| Bottom Line Profit Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | |
| Current Ratio | 0.788 | 0.827 | 0.792 | 0.774 | 0.789 | |
| Quick Ratio | 0.788 | 0.827 | 0.792 | 0.774 | 0.789 | |
| Solvency Ratio | 0.079 | 0.095 | 0.151 | 0.148 | 0.150 | |
| Cash Ratio | 0.212 | 0.244 | 0.257 | 0.262 | 0.273 | |
| Price To Earnings Ratio | 24.952 | 32.344 | 22.361 | 24.614 | 27.394 | |
| Price To Earnings Growth Ratio | -1.619 | -0.920 | 1.867 | 1.406 | 2.176 | |
| Forward Price To Earnings Growth Ratio | -1.619 | -0.920 | 1.867 | 1.406 | 2.176 | |
| Price To Earnings Diluted Ratio | 24.952 | 32.615 | 22.604 | 25.032 | 27.773 | |
| Price To Earnings Diluted Growth Ratio | -1.697 | -0.932 | 1.786 | 1.460 | 2.172 | |
| Price To Book Ratio | 3.192 | 5.072 | 5.639 | 6.367 | 6.599 | |
| Price To Sales Ratio | 0.671 | 1.174 | 1.347 | 1.528 | 1.646 | |
| Price To Free Cash Flow Ratio | 18.687 | 22.697 | 19.489 | 21.158 | 23.808 | |
| Price To Operating Cash Flow Ratio | 15.251 | 19.416 | 17.219 | 18.896 | 21.193 | |
| Debt To Assets Ratio | 0.253 | 0.258 | 0.246 | 0.235 | 0.217 | |
| Debt To Equity Ratio | 0.833 | 0.830 | 0.760 | 0.741 | 0.641 | |
| Debt To Capital Ratio | 0.454 | 0.454 | 0.432 | 0.426 | 0.391 | |
| Long Term Debt To Capital Ratio | 0.435 | 0.438 | 0.396 | 0.412 | 0.371 | |
| Financial Leverage Ratio | 3.290 | 3.219 | 3.084 | 3.159 | 2.957 | |
| Working Capital Turnover Ratio | -21.159 | -20.736 | -18.223 | -17.665 | -16.324 | |
| Operating Cash Flow Ratio | 0.171 | 0.233 | 0.293 | 0.294 | 0.285 | |
| Operating Cash Flow Sales Ratio | 0.044 | 0.060 | 0.078 | 0.081 | 0.078 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.816 | 0.855 | 0.884 | 0.893 | 0.890 | |
| Debt Service Coverage Ratio | 2.102 | 2.751 | 3.548 | 5.023 | 4.260 | |
| Interest Coverage Ratio | 4.739 | 8.266 | 9.969 | 13.592 | 14.440 | |
| Short Term Operating Cash Flow Coverage Ratio | 3.246 | 5.325 | 5.472 | 8.426 | 6.172 | |
| Operating Cash Flow Coverage Ratio | 0.251 | 0.315 | 0.431 | 0.455 | 0.486 | |
| Capital Expenditure Coverage Ratio | 5.438 | 6.917 | 8.585 | 9.353 | 9.105 | |
| Dividend Paid And Capex Coverage Ratio | 1.707 | 2.194 | 2.865 | 2.980 | 2.889 | |
| Dividend Payout Ratio | 0.657 | 0.523 | 0.302 | 0.298 | 0.305 | |
| Enterprise Value Multiple | 15.370 | 18.576 | 14.933 | 16.631 | 18.400 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 18.5% | ▼-3.8% | ▼-4.3% |
| Ebit Margin | 4.2% | ▼-1.8% | ▼-3.0% |
| Ebitda Margin | 5.1% | ▼-1.9% | ▼-3.1% |
| Operating Profit Margin | 4.2% | ▼-3.8% | ▼-3.4% |
| Pretax Profit Margin | 3.3% | ▼-1.7% | ▼-3.1% |
| Continuous Operations Profit Margin | 2.9% | ▼-0.9% | ▼-2.2% |
| Net Profit Margin | 2.7% | ▼-0.9% | ▼-2.2% |
| Bottom Line Profit Margin | 2.7% | ▼-0.9% | ▼-2.2% |
| Current Ratio | 0.788 | ▼-0.038 | ▼-0.006 |
| Quick Ratio | 0.788 | ▼-0.038 | ▼-0.006 |
| Solvency Ratio | 0.079 | ▼-0.016 | ▼-0.045 |
| Cash Ratio | 0.212 | ▼-0.032 | ▼-0.037 |
| Price To Earnings Ratio | 24.952 | ▼-7.392 | ▼-1.381 |
| Price To Earnings Growth Ratio | -1.619 | ▼-0.699 | ▼-2.201 |
| Forward Price To Earnings Growth Ratio | -1.619 | ▼-0.699 | ▼-2.201 |
| Price To Earnings Diluted Ratio | 24.952 | ▼-7.663 | ▼-1.644 |
| Price To Earnings Diluted Growth Ratio | -1.697 | ▼-0.765 | ▼-2.255 |
| Price To Book Ratio | 3.192 | ▼-1.880 | ▼-2.182 |
| Price To Sales Ratio | 0.671 | ▼-0.503 | ▼-0.602 |
| Price To Free Cash Flow Ratio | 18.687 | ▼-4.010 | ▼-2.481 |
| Price To Operating Cash Flow Ratio | 15.251 | ▼-4.165 | ▼-3.144 |
| Debt To Assets Ratio | 0.253 | ▼-0.005 | ▲0.011 |
| Debt To Equity Ratio | 0.833 | ▲0.003 | ▲0.072 |
| Debt To Capital Ratio | 0.454 | ▲0.001 | ▲0.023 |
| Long Term Debt To Capital Ratio | 0.434 | ▼-0.004 | ▲0.024 |
| Financial Leverage Ratio | 3.290 | ▲0.070 | ▲0.148 |
| Working Capital Turnover Ratio | -21.159 | ▼-0.423 | ▼-2.338 |
| Operating Cash Flow Ratio | 0.171 | ▼-0.062 | ▼-0.084 |
| Operating Cash Flow Sales Ratio | 0.044 | ▼-0.017 | ▼-0.024 |
| Free Cash Flow Operating Cash Flow Ratio | 0.816 | ▼-0.039 | ▼-0.051 |
| Debt Service Coverage Ratio | 2.102 | ▼-0.649 | ▼-1.435 |
| Interest Coverage Ratio | 4.739 | ▼-3.527 | ▼-5.462 |
| Short Term Operating Cash Flow Coverage Ratio | 3.245 | ▼-2.080 | ▼-2.483 |
| Operating Cash Flow Coverage Ratio | 0.251 | ▼-0.064 | ▼-0.136 |
| Capital Expenditure Coverage Ratio | 5.438 | ▼-1.479 | ▼-2.441 |
| Dividend Paid And Capex Coverage Ratio | 1.707 | ▼-0.487 | ▼-0.820 |
| Dividend Payout Ratio | 0.657 | ▲0.134 | ▲0.240 |
| Enterprise Value Multiple | 15.370 | ▼-3.206 | ▼-1.412 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $300.40B | $469.94B | $500.51B | $495.19B | $473.52B | |
| Enterprise value | $354.42B | $521.54B | $542.52B | $529.45B | $498.15B | |
| EV / Sales | 0.79x | 1.30x | 1.46x | 1.63x | 1.73x | |
| EV / Op. cash flow | 17.99x | 21.55x | 18.66x | 20.20x | 22.30x | |
| EV / Free cash flow | 22.05x | 25.19x | 21.12x | 22.62x | 25.05x | |
| EV / EBITDA | 15.37x | 18.58x | 14.93x | 16.63x | 18.40x | |
| Net debt / EBITDA | 2.34x | 1.84x | 1.16x | 1.08x | 0.91x | |
| Current ratio | 0.79x | 0.83x | 0.79x | 0.77x | 0.79x | |
| Income quality | 1.54x | 1.59x | 1.30x | 1.30x | 1.29x | |
| Graham number | $176 | $187 | $228 | $201 | $177 | |
| Graham net-net | -$154 | -$140 | -$125 | -$116 | -$96 | |
| Tax burden | 82.0% | 71.8% | 76.9% | 76.4% | 77.5% | |
| Interest burden | 78.6% | 83.7% | 90.0% | 92.6% | 93.1% | |
| Working capital | -$24.32B | -$17.99B | -$20.62B | -$20.17B | -$16.53B | |
| Invested capital | $117.42B | $122.56B | $109.76B | $97.71B | $78.27B | |
| Return on assets | 3.9% | 4.8% | 8.2% | 8.2% | 8.1% | |
| Operating ROA | 6.2% | 11.3% | 12.5% | 12.4% | 11.7% | |
| Return on tangible assets | 6.7% | 8.6% | 14.5% | 14.6% | 13.7% | |
| Return on equity | 12.8% | 15.5% | 25.2% | 25.9% | 24.1% | |
| Return on invested capital | 8.2% | 12.3% | 14.3% | 14.0% | 13.9% | |
| Return on capital employed | 9.7% | 16.6% | 18.5% | 18.2% | 17.9% | |
| Earnings yield | 4.0% | 3.1% | 4.5% | 4.1% | 3.7% | |
| Free cash flow yield | 5.4% | 4.4% | 5.1% | 4.7% | 4.2% | |
| Capex / Op. cash flow | 18.4% | 14.5% | 11.6% | 10.7% | 11.0% | |
| Capex / Depreciation | 83.1% | 85.4% | 85.2% | 82.4% | 79.1% | |
| Capex / Sales | 0.8% | 0.9% | 0.9% | 0.9% | 0.9% | |
| SG&A / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | |
| Intangibles / Total assets | 42.3% | 43.6% | 43.4% | 43.9% | 40.5% | |
| Days sales outstanding | 43d | 44d | 38d | 34d | 36d | |
| Days payables outstanding | 77d | 80d | 42d | 85d | 82d | |
| Operating cycle | 43d | 44d | 38d | 34d | 36d | |
| Cash conversion cycle | -34d | -36d | -3d | -50d | -47d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-36.1%EV / Sales ▼-39.2%EV / EBITDA ▼-17.3%EV / Op. cash flow ▼-3.554Earnings yield ▲+0.009Graham number ▼-10.963
Profitability
Return on equity ▼-0.027Return on assets ▼-0.009Return on invested capital ▼-0.041Return on capital employed ▼-0.069Operating ROA ▼-0.050Income quality ▼-0.050Tax burden ▲+0.103
Efficiency
Days sales outstanding ▼-1.193Days payables outstanding ▼-3.054Operating cycle ▼-1.193Cash conversion cycle ▲+1.860Capex / Sales ▼-0.001R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.038Net debt / EBITDA ▲+0.505Working capital ▼-6325000000.000Invested capital ▼-5145000000.000Intangibles / Total assets ▼-0.013
Change over 5 years
Valuation
Market cap ▼-36.6%EV / Sales ▼-54.3%EV / EBITDA ▼-16.5%EV / Op. cash flow ▼-4.302Earnings yield ▲+0.004Graham number ▼-1.578
Profitability
Return on equity ▼-0.113Return on assets ▼-0.043Return on invested capital ▼-0.056Return on capital employed ▼-0.082Operating ROA ▼-0.055Income quality ▲+0.245Tax burden ▲+0.046
Efficiency
Days sales outstanding ▲+7.350Days payables outstanding ▼-4.830Operating cycle ▲+7.350Cash conversion cycle ▲+12.180Capex / Sales -0.000R&D / Sales n/a
Balance-sheet strength
Current ratio -0.000Net debt / EBITDA ▲+1.433Working capital ▼-7781000000.000Invested capital ▲+39146000000.000Intangibles / Total assets ▲+0.019
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-10 | Dan Newhouse | Sale | $1,001 - $15,000 |
| 2026-06-12 | Rich McCormick | Sale | $1,001 - $15,000 |
| 2026-06-04 | Maria Elvira Salazar | Sale | $1,001 - $15,000 |
| 2026-04-22 | Maria Elvira Salazar | Purchase | $1,001 - $15,000 |
| 2026-04-22 | Maria Elvira Salazar | Purchase | $1,001 - $15,000 |
| 2026-04-22 | Maria Elvira Salazar | Purchase | $1,001 - $15,000 |
| 2026-03-30 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-03-19 | Richard Dean Dr McCormick | Purchase | $1,001 - $15,000 |
| 2026-02-20 | Charles J. "Chuck" Fleischmann | Purchase | $15,001 - $50,000 |
| 2026-02-10 | Gilbert Cisneros | Sale | $15,001 - $50,000 |
| 2026-02-05 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2026-01-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-12-23 | Kevin Hern | Sale | $250,001 - $500,000 |
| 2025-12-19 | Gilbert Cisneros | Purchase | $15,001 - $50,000 |
| 2025-12-18 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-11-13 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-11-12 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2025-11-05 | Rich McCormick | Purchase | $1,001 - $15,000 |
| 2025-11-04 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-10-09 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Valerie Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-09-18 | Rich McCormick | Sale | $1,001 - $15,000 |
| 2025-09-05 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2025-09-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-28 | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2025-08-15 | Tim Moore | Sale | $50,001 - $100,000 |
| 2025-08-14 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-08-08 | Tim Moore | Purchase | $15,001 - $50,000 |
| 2025-08-05 | Gilbert Cisneros | Sale (Partial) | $15,001 - $50,000 |
| 2025-08-04 | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |
| 2025-08-01 | Tim Moore | Purchase | $1,001 - $15,000 |
| 2025-07-24 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-07-21 | Tim Moore | Purchase | $1,001 - $15,000 |
| 2025-07-16 | Tim Moore | Purchase | $15,001 - $50,000 |
| 2025-06-24 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-05-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-05-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-05-27 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2025-05-20 | Michael McCaul | Purchase | $50,001 - $100,000 |
| 2025-05-16 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-05-16 | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Jared Moskowitz | Sale | $1,001 - $15,000 |
| 2025-05-15 | Jared Moskowitz | Sale | $1,001 - $15,000 |
| 2025-05-15 | Jared Moskowitz | Sale | $1,001 - $15,000 |
| 2025-05-15 | Rob Bresnahan | Sale | $15,001 - $50,000 |
| 2025-05-14 | David Taylor | Sale | $15,001 - $50,000 |
| 2025-05-14 | David Taylor | Sale | $1,001 - $15,000 |
| 2025-05-14 | Marjorie Taylor Greene | Purchase | $15,001 - $50,000 |
| 2025-05-06 | Valerie Hoyle | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-29 | Valerie Hoyle | Purchase | $1,001 - $15,000 |
| 2025-04-24 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-04-22 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2025-04-15 | Valerie Hoyle | Purchase | $1,001 - $15,000 |
| 2025-04-11 | Dan Newhouse | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-10 | John McGuire | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan | Purchase | $15,001 - $50,000 |
| 2025-03-31 | Gilbert Cisneros | Purchase | $15,001 - $50,000 |
| 2025-03-27 | Greg Landsman | Sale | $15,001 - $50,000 |
| 2025-03-13 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-02-26 | Gilbert Cisneros | Sale | $15,001 - $50,000 |
| 2025-02-24 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-01-24 | Valerie Hoyle | Sale (Partial) | $1,001 - $15,000 |
| 2025-01-24 | Gilbert Cisneros | Purchase | $15,001 - $50,000 |
| 2025-01-14 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-01-09 | Michael McCaul | Sale | $50,001 - $100,000 |
| 2025-01-07 | Rick Larsen | Sale (Full) | $1,001 - $15,000 |
| 2024-11-19 | Michael McCaul | Sale | $50,001 - $100,000 |
| 2024-11-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-10-29 | Valerie Hoyle | Purchase | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2024-10-11 | Earl Blumenauer | Sale | $15,001 - $50,000 |
| 2024-09-26 | Ritchie Torres | Purchase | $1,001 - $15,000 |
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-08-07 | Scott Mr Franklin | Purchase | $1,001 - $15,000 |
| 2024-05-03 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2024-05-03 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2024-04-12 | Mike Kelly | Sale | $1,001 - $15,000 |
| 2024-03-25 | Michael McCaul | Exchange | $250,001 - $500,000 |
| 2024-03-25 | Michael McCaul | Sale | $250,001 - $500,000 |
| 2024-03-25 | Michael McCaul | Sale | $250,001 - $500,000 |
| 2024-03-25 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-03-19 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2024-03-19 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2024-02-21 | Michael McCaul | Purchase | $100,001 - $250,000 |
| 2024-02-21 | Michael McCaul | Purchase | $100,001 - $250,000 |
| 2024-02-13 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2023-12-04 | John Curtis | Sale | $1,001 - $15,000 |
| 2023-11-10 | John James | Purchase | $1,001 - $15,000 |
| 2023-10-26 | Ro Khanna | Sale | $50,001 - $100,000 |
| 2023-10-24 | Greg Stanton | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-28 | Robert J. Wittman | Sale (Full) | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton | Purchase | $1,001 - $15,000 |
| 2023-09-19 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2023-07-14 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2023-03-15 | Richard Dean Dr McCormick | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-03 The Big 3: ARM, RSI, UNH Arm Holdings (ARM), Rush Street Interactive (RSI) and UnitedHealth (UNH) are today''s trio of charts and trades. Mike Shorr (@ProsperTradingAcademy) provides his fundamental analysis on the stocks and demonstrates example options strategies for each.
- 2026-08-03 FAS Wealth Partners Inc. Acquires 8,239 Shares of UnitedHealth Group Incorporated $UNH FAS Wealth Partners Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 270.7% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 11,283 shares of the healthcare conglomerate''s stock after purchasing an additional 8,239 shares during the period. FAS Wealth Partners Inc.''s
- 2026-07-31 UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy? UNH''s diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.
- 2026-07-31 Medicare Advantage Insurers Are Redrawing the Map for 2027. Members Find Out by Letter This Fall. Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees do next could cost thousands of dollars or make coverage impossible to find.
- 2026-07-31 Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock''s price, do they really matter?
- 2026-07-29 UnitedHealth''s Cost-Control Story is Gaining Momentum: Time to Buy? UNH''s improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.
- 2026-07-29 Buy These 3 Blue-Chip Stocks After Strong Q2 2026 Earnings Results MMM, TRV and UNH posted strong Q2 results, with higher guidance, investment strength and growth drivers supporting their 2026 outlooks.
- 2026-07-29 UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee --(BUSINESS WIRE)--UnitedHealth Group today announced new support to expand the University of Tennessee Health Sciences'' health hub model statewide, helping more Tennesseans access preventive care, chronic condition support and local health resources in their communities. The new support includes a $4 million commitment, with funding from the United Health Foundation and technical assistance from UnitedHealth Group, to expand the network from five health hubs to 13 across the state by the end o.
- 2026-07-29 UnitedHealth Group Incorporated $UNH Stake Lowered by Amundi Amundi lowered its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 13.3% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 6,376,198 shares of the healthcare conglomerate''s stock after selling 979,859 shares during the period. Amundi owned 0.70% of UnitedHealth Group worth $1,725,334,000 as
- 2026-07-28 Wolfe says buy these three quality stocks into post-earnings strength July has dealt Wall Street a turbulent hand. US stocks have drifted lower this month, hampered by persistent geopolitical risks, rising crude oil prices, and mounting anxiety over rising AI capex.